Medindia

X

LVRS Increases Survival Rates among Emphysema Patients

by Medindia Content Team on  August 6, 2006 at 12:12 PM Research News   - G J E 4
LVRS Increases Survival Rates among Emphysema Patients
According to the trail conducted by National Emphysema Treatment Trial (NETT) it was found that emphysema patients benefited from surgery that those who take medications.
Advertisement

The bilateral lung volume reduction surgery (LVRS) to treat severe emphysema has resulted in increased survival rates among these patients. NETT researchers describe the effects of LVRS after following 1218 patients for an average of 4.3 years, two years longer than the primary results reported in 2003. The earlier findings led to Medicare coverage of LVRS for patients meeting criteria based on the study results.

Advertisement
NETT began in 1996 as a cooperative effort between the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health and the Centers for Medicare & Medicaid Services. Both are agencies of the U.S. Department of Health and Human Services. 'Long-Term Follow-Up of Patients Receiving Lung-Volume-Reduction Surgery Versus Medical Therapy for Severe Emphysema' is published in the August issue of the Annals of Thoracic Surgery. Gail Weinmann, M.D., director of the NHLBI Airway Biology and Disease Program, is available to comment on the study's findings.

Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All